Atlas Trials

Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients

Clinical trial NCT00138879 · COMPLETED

Trial details

NCT number
NCT00138879
Sponsor
St Mark's Hospital Foundation
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn's DiseaseShort Bowel SyndromeMalabsorption SyndromesCeliac Disease
Start date
2003-05-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.